Blood glucose meter
Latest Roche Diabetes Care, Inc. Patents:
- Method for determining at least one membrane property of an analyte sensor
- Cannula unit
- Method for evaluating suitability of lighting conditions for detecting an analyte in a sample using a camera of a mobile device
- Methods of correcting for uncompensated resistances in the conductive elements of biosensors, as well as devices and systems incorporating the same
- Methods and devices for performing an analytical measurement
Description
The broken lines represent the bounds of the claim and form no part of the claimed design.
Claims
The ornamental design for a blood glucose meter, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
D406895 | March 16, 1999 | Byrd et al. |
D548347 | August 7, 2007 | Ichino |
D611853 | March 16, 2010 | Salter et al. |
D628915 | December 14, 2010 | Faulkner |
D646787 | October 11, 2011 | Presta et al. |
D648029 | November 1, 2011 | Presta et al. |
D713963 | September 23, 2014 | Liedtke |
D721177 | January 13, 2015 | Ahlstrom et al. |
D721178 | January 13, 2015 | Harkin et al. |
D737980 | September 1, 2015 | Golnik |
20100113896 | May 6, 2010 | Cadio et al. |
- Accu-Chek® Advantage Meter System, www.accu-chek.com/us/glucose-meters/advantage.html (printed therefrom on Apr. 15, 2014).
- Accu-Chek® Aviva Plus System, www.accu-chek.com/us/glucose-meters/aviva.html (printed therefrom on Apr. 15, 2014).
- Accu-Chek® Compact Plus Meter System, www.accu-chek.com/us/glucose-meters/compact-plus.html (printed therefrom on Apr. 15, 2014).
- Accu-Chek® Nano Meter, www.accu-chek.com/us/glucose-meters/nano.html (printed therefrom on Apr. 15, 2014).
- Design U.S. Appl. No. 29/490,205, filed May 7, 2014 to Roche Diagnostics Operations, Inc.
Patent History
Patent number: D778445
Type: Grant
Filed: Aug 20, 2015
Date of Patent: Feb 7, 2017
Assignee: Roche Diabetes Care, Inc. (Indianapolis, IN)
Inventors: Michel A. Cadio (Carmel, IN), Thomas Z. Harkin (Bristol), David C. Krey (Heidelberg), Sebastian Liedtke (Heidelberg), Jessica Wiedemann (Lampertheim)
Primary Examiner: Anhdao Doan
Application Number: 29/536,902
Type: Grant
Filed: Aug 20, 2015
Date of Patent: Feb 7, 2017
Assignee: Roche Diabetes Care, Inc. (Indianapolis, IN)
Inventors: Michel A. Cadio (Carmel, IN), Thomas Z. Harkin (Bristol), David C. Krey (Heidelberg), Sebastian Liedtke (Heidelberg), Jessica Wiedemann (Lampertheim)
Primary Examiner: Anhdao Doan
Application Number: 29/536,902
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)